Equity Research Security & Commodity Brokers, Dealers, Exchanges & Services

Should You Buy Marex Group Limited Stock in 2026?

By CirclFi Research Team · · 10/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Marex Group Limited (MRX) is rated as a strong fundamental performer with a QOC score of 9.0/10. Trading at $62.62, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 8 of 10 CirclFi valuation models project upside for Marex Group Limited (MRX) at $62.62 — the model consensus leans bullish, with a Quality Score of 9.0/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 8 of 10 models see upside — majority bullish
  • Quality Score: 9.0/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: 6/100 — Minimal — healthy fundamentals
  • Fair Value Range: $42.00 – $215.34 (413% spread)

Bullish Models

8 / 10

Bearish Models

2 / 10

Quality Score

9.0 /10

Excellent — top-tier fundamentals

Value Trap Risk

6 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

10 /13
Active Models

Avg. confidence: 31%

Investment Thesis

The Bull Case

Target: $215.34 (+243.9% upside)

  • According to the CirclFi Quality of Company (QOC) framework, Marex Group Limited's score of 9.0/10 reflects durable competitive advantages that should sustain earnings power through market cycles.
  • According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with an average implied return of +48.5% across 6 bullish models from the current price of $62.62.
  • According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $215.34 (+243.9%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously.

The Bear Case

Target: $42.00 (-32.9%)

  • According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $42.00 (-32.9%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +276.8% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

Peer Benchmarking

TW Tradeweb Markets Inc
10.0
CBOE Cboe Global Markets,
10.0
CME CME Group Inc.
8.9
SNEX StoneX Group Inc.
8.6
ICE Intercontinental Exc
8.6

Valuation Divergence

Spread

413%

Fair Value Range

$42.00 – $215.34

A 413% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

First Chicago

$215.34 (+243.9%)

Most Bearish

EPV

$42.00 (-32.9%)

Key Risk Factors

Model Disagreement

413% spread signals high variance in projections.

Macro/Sector Risk

Security & Commodity Brokers, Dealers, Exchanges & Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View MRX Data Page →

The Bottom Line

The balance of evidence tilts cautiously positive for Marex Group Limited at $62.62. 6 of 10 models support upside to $92.99, backed by a 9.0/10 quality foundation. This is a "lean into, not load up on" setup in our framework.

These are quantitative model outputs, not investment recommendations. Marex Group Limited's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy MRX stock right now?

Based on CirclFi's multi-model analysis, 8 of 10 models see upside for MRX at $62.62. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 9.0/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Marex Group Limited?

Key risks include: wide model disagreement (413% spread), signaling high uncertainty; general market and sector-specific risks affecting Security & Commodity Brokers, Dealers, Exchanges & Services companies. Always diversify and consult a financial advisor.

How does MRX compare to its competitors?

Among Security & Commodity Brokers, Dealers, Exchanges & Services peers, MRX holds a Quality Score of 9.0/10. Comparable companies include TW (QOC 10.0), CBOE (QOC 10.0), CME (QOC 8.9). The relative ranking helps investors identify whether MRX offers better fundamental quality than alternatives in the same sector.

Is MRX a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. MRX's Quality Score of 9.0/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy MRX at?

CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $42.00 to $215.34. At $62.62, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for MRX.

View MRX Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →